Announcements
- Bavarian Nordic Converts Existing Credit Facility into Sustainability-linked Loan
- Bavarian Nordic konverterer eksisterende kreditfacilitet til bæredygtighedsrelateret lån
- Bavarian Nordic tilslutter sig globalt initiativ i kampen mod mpox i Afrika
- Bavarian Nordic Joins Global Efforts to Fight Mpox Outbreak in Africa
- Bavarian Nordic Submits Marketing Authorization Application for its Chikungunya Vaccine Candidate to EMA
- Bavarian Nordic indsender registreringsansøgning for chikungunyavaccine til de europæiske sundhedsmyndigheder
- Bavarian Nordic indsender registreringsansøgning for chikungunya-vaccine til de amerikanske sundhedsmyndigheder
- Bavarian Nordic Completes BLA Submission to U.S. FDA for its Chikungunya Vaccine Candidate
- Bavarian Nordic Submits Supplemental BLA Seeking U.S. FDA Approval of Freeze-Dried Formulation of Smallpox and Mpox Vaccine
- Bavarian Nordic indsender supplerende ansøgning til de amerikanske sundhedsmyndigheder om godkendelse af frysetørret koppe- og mpoxvaccine
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 78.12m |
Free float | 78.05m |
P/E (TTM) | 13.71 |
Market cap | 13.77bn DKK |
EPS (TTM) | 12.86 DKK |
--
More ▼